Edition:
United States

TapImmune Inc (TPIV.OQ)

TPIV.OQ on NASDAQ Stock Exchange Capital Market

3.15USD
1:02pm EST
Change (% chg)

$-0.01 (-0.32%)
Prev Close
$3.16
Open
$3.11
Day's High
$3.15
Day's Low
$3.10
Volume
2,633
Avg. Vol
4,660
52-wk High
$5.35
52-wk Low
$2.62

Select another date:

Wed, Nov 15 2017

BRIEF-Tapimmune Q3 loss earnings per share $0.39‍​

* Tapimmune provides third quarter 2017 corporate and clinical update

BRIEF-TapImmune appoints Peter Hoang as president and CEO

* TapImmune appoints Peter Hoang as president and chief executive officer

BRIEF-Tapimmune files for‍​ resale of 4.4 mln shares of common stock held by selling stockholders

* Tapimmune Inc - Files for‍​ resale 4.4 million shares of common stock which are currently held by selling stockholders - SEC filing Source text: [http://bit.ly/2hjwILz] Further company coverage:

BRIEF-TapImmune reaches 50 pct patient enrollment benchmark in phase 2 study of novel t-cell vaccine targeting triple-negative breast cancer

* TapImmune reaches 50% patient enrollment benchmark in phase 2 study of novel t-cell vaccine targeting triple-negative breast cancer

BRIEF-TapImmune to raise $6.82 million in a private placement

* Tapimmune inc. Enters into definitive agreements to raise $6.82 million in a private placement from accredited investors and from the exercise of warrants by existing institutional investors

Select another date: